MRVL Latest News

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Press ReleaseN/A

Calgary, Alberta--(Newsfile Corp. - April 8, 2026) - Marvel Biosciences Corp.

Marvell Technology, Inc. Declares Quarterly Dividend Payment

Press ReleaseN/A

SANTA CLARA, Calif. --(BUSINESS WIRE)--Marvell Technology, Inc.

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Press ReleaseN/A

Calgary, Alberta--(Newsfile Corp. - March 18, 2026) - Marvel Biosciences Corp.

Marvell Launches Next-generation CXL Switch, Enabling Memory Pooling to Break Through the AI “Memory Wall”

Press ReleaseN/A

LOS ANGELES--(BUSINESS WIRE)---- $MRVL #AI--OFC 2026 – Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutio

Marvell Launches Industry's First 260-lane PCIe 6.0 Switch for AI Data Center Scale-up Infrastructure

Press ReleaseN/A

LOS ANGELES--(BUSINESS WIRE)---- $MRVL #AI--OFC 2026 – Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutio